NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i
|
|
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:
|
Diaceutics PLC
|
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)
|
Non-UK issuer
|
|
2. Reason for the notification (please mark the appropriate box or boxes with an "X")
|
An acquisition or disposal of voting rights
|
X
|
An acquisition or disposal of financial instruments
|
|
An event changing the breakdown of voting rights
|
|
Other (please specify) iii:
|
|
3. Details of person subject to the notification obligation iv
|
Name
|
Gresham House Asset Management Ltd
|
City and country of registered office (if applicable)
|
London, UK
|
4. Full name of shareholder(s) (if different from 3.) v
|
Name
|
|
City and country of registered office (if applicable)
|
London, UK
|
5. Date on which the threshold was crossed or reached vi:
|
01/10/2024
|
6. Date on which issuer notified (DD/MM/YYYY):
|
07/10/2024
|
7. Total positions of person(s) subject to the notification obligation
|
|
% of voting rights attached to shares (total of 8. A)
|
% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)
|
Total of both in % (8.A + 8.B)
|
Total number of voting rights held in issuer (8.A + 8.B) vii
|
Resulting situation on the date on which threshold was crossed or reached
|
13.09%
|
|
13.09%
|
11,093,500
|
Position of previous notification (if
applicable)
|
12.36%
|
|
12.36%
|
|
|
|
|
|
|
|
|